Capsid Tropism Screening Platforms Market Expected To Add Significant Value By 2030, Supported By A 14.4% CAGR

 The Business Research Company’s 2026 market reports incorporate enhanced features, including market attractiveness scoring and analysis, total addressable market evaluation, a company scoring matrix, an interactive Excel data dashboard, refined supply chain analysis, insights on emerging startups, and overviews of key products, all aimed at improving the depth, usability, and strategic relevance of the insights delivered.

What Will Be The Estimated Market Value Of The Capsid Tropism Screening Platforms Market By The End Of The Forecast Timeline?
The capsid tropism screening platforms market size has grown rapidly in recent years. It will grow from $0.74 billion in 2025 to $0.85 billion in 2026 at a compound annual growth rate (CAGR) of 14.2%. The growth in the historic period can be attributed to increasing investment in gene therapy research, growing demand for viral vector optimization, adoption of flow cytometry and sequencing technologies, rising focus on personalized medicine, expansion of pharmaceutical and biotech R&D infrastructure.

The capsid tropism screening platforms market size is expected to see rapid growth in the next few years. It will grow to $1.45 billion in 2030 at a compound annual growth rate (CAGR) of 14.4%. The growth in the forecast period can be attributed to growing use of AI-driven capsid tropism analysis, increasing deployment of high-content imaging and microfluidics, rising demand for single-cell sequencing and advanced screening platforms, expansion of contract research organizations (CROs), increasing integration of multiplex assay and digital PCR technologies. Major trends in the forecast period include increasing adoption of high-throughput screening platforms, rising demand for next-generation sequencing solutions, growing integration of flow cytometry technologies, expansion of assay kits and reagent offerings, rising focus on gene therapy and vaccine development applications.

Download Your Free Report Sample:
https://www.thebusinessresearchcompany.com/sample_request?id=65623372&type=smp&name=Capsid%20Tropism%20Screening%20Platforms%20Market%20Report%202026

What Key Factors Are Contributing To The Growth Of The Capsid Tropism Screening Platforms Market?
The increasing demand for targeted gene therapies is expected to drive the growth of the capsid tropism screening platforms market over the forecast period. Targeted gene therapies involve delivering therapeutic genetic material to specific cells or tissues to correct, modify, or replace defective genes responsible for disease. The rising demand for these therapies is driven by multiple factors, including the growing prevalence of genetic and rare diseases, advances in vector engineering technologies, and increased investment in precision medicine approaches that aim to improve treatment efficacy while minimizing off-target effects. Capsid tropism screening platforms play a critical role in gene therapy development by enabling the systematic evaluation and selection of viral vectors with optimal tissue and cell specificity. For instance, in January 2024, according to the American Society of Gene & Cell Therapy, a US-based organization for gene and cell therapy, the number of gene therapies in Phase III clinical trials increased by 10% in the fourth quarter of 2023, representing the first quarterly increase since the third quarter of 2022. Therefore, the increasing demand for targeted gene therapies is driving the growth of the capsid tropism screening platforms market.

Which Companies Should Be Closely Watched In The Capsid Tropism Screening Platforms Market?
The capsid tropism screening platforms market covered in this report is segmented –

1) By Technology: High-Throughput Screening, Next-Generation Sequencing, Flow Cytometry, Other Technologies
2) By Product Type: Assay Kits, Reagents, Instruments, Software, Services
3) By Application: Gene Therapy Development, Vaccine Development, Drug Discovery, Other Applications
4) By End-User: Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Contract Research Organizations, Other End-Users

Subsegments:
1) By High-Throughput Screening: Cell-Based Screening, Biochemical Screening, High-Content Screening, Automated Screening, Label-Free Screening
2) By Next-Generation Sequencing: Short-Read Sequencing, Long-Read Sequencing, Targeted Sequencing, Whole-Genome Sequencing, Single-Cell Sequencing
3) By Flow Cytometry: Conventional Flow Cytometry, Spectral Flow Cytometry, Imaging Flow Cytometry, Cell Sorting, Mass Cytometry
4) By Other Technologies: Microfluidics-Based Screening, High-Content Imaging, Mass Spectrometry, Polymerase Chain Reaction And Digital Polymerase Chain Reaction, Immunoassay-Based Platforms

What Are The Most Important Trends In The Capsid Tropism Screening Platforms Market?
Major companies operating in the capsid tropism screening platforms market are forming strategic partnerships to develop innovative high-throughput and barcoded adeno-associated virus screening solutions. Strategic partnerships propel the growth of the capsid tropism screening platforms market by enabling collaborative development of advanced adeno-associated virus screening technologies, expanding product portfolios, and accelerating gene therapy research and commercialization. For instance, in August 2025, PackGene Biotech Inc., a US-based biotechnology company, entered a strategic licensing agreement with the Children’s Medical Research Institute (CMRI), an Australia-based independent organization, to commercialize barcoded high-throughput adeno-associated virus capsid screening kits. These kits enable researchers to rapidly evaluate multiple adeno-associated virus capsid variants simultaneously using a barcode system and next-generation sequencing. The collaboration aims to accelerate gene therapy development by streamlining capsid selection and improving access to advanced screening tools.

How Is The Capsid Tropism Screening Platforms Market Divided Into Segment Categories?
The capsid tropism screening platforms market covered in this report is segmented –

1) By Technology: High-Throughput Screening, Next-Generation Sequencing, Flow Cytometry, Other Technologies
2) By Product Type: Assay Kits, Reagents, Instruments, Software, Services
3) By Application: Gene Therapy Development, Vaccine Development, Drug Discovery, Other Applications
4) By End-User: Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Contract Research Organizations, Other End-Users

Subsegments:
1) By High-Throughput Screening: Cell-Based Screening, Biochemical Screening, High-Content Screening, Automated Screening, Label-Free Screening
2) By Next-Generation Sequencing: Short-Read Sequencing, Long-Read Sequencing, Targeted Sequencing, Whole-Genome Sequencing, Single-Cell Sequencing
3) By Flow Cytometry: Conventional Flow Cytometry, Spectral Flow Cytometry, Imaging Flow Cytometry, Cell Sorting, Mass Cytometry
4) By Other Technologies: Microfluidics-Based Screening, High-Content Imaging, Mass Spectrometry, Polymerase Chain Reaction And Digital Polymerase Chain Reaction, Immunoassay-Based Platforms

Explore the Complete Capsid Tropism Screening Platforms Market Report:
https://www.thebusinessresearchcompany.com/report/capsid-tropism-screening-platforms-market-report

How Does Growth In The Capsid Tropism Screening Platforms Market Differ Across Major Regions?
North America was the largest region in the capsid tropism screening platforms market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the capsid tropism screening platforms market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Contact Us:

The Business Research Company: https://thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: marketing@tbrc.info

Follow Us On:

LinkedIn: The Business Research Company | LinkedIn